Quest Partners LLC Has $30,000 Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Quest Partners LLC lifted its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 2,826.7% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 439 shares of the company’s stock after purchasing an additional 424 shares during the period. Quest Partners LLC’s holdings in Prestige Consumer Healthcare were worth $30,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Opal Wealth Advisors LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 2nd quarter worth about $26,000. Principal Securities Inc. acquired a new position in Prestige Consumer Healthcare in the 4th quarter valued at $29,000. EverSource Wealth Advisors LLC increased its position in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after buying an additional 208 shares during the period. Gladius Capital Management LP acquired a new stake in shares of Prestige Consumer Healthcare during the second quarter worth $35,000. Finally, ORG Partners LLC bought a new stake in shares of Prestige Consumer Healthcare in the second quarter valued at about $39,000. Institutional investors and hedge funds own 99.95% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, DA Davidson raised their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $98.75.

Prestige Consumer Healthcare Price Performance

Shares of NYSE PBH opened at $73.01 on Friday. The business has a fifty day moving average price of $71.22 and a two-hundred day moving average price of $69.67. The stock has a market capitalization of $3.62 billion, a PE ratio of 17.51, a P/E/G ratio of 2.08 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.34 and a fifty-two week high of $75.80.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.04. The business had revenue of $267.10 million during the quarter, compared to analysts’ expectations of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. Prestige Consumer Healthcare’s revenue was down 4.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.06 earnings per share. As a group, equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.